Serum salusin-alpha level in rheumatoid arthritis

Regulatory Peptides

Volumn 167, Issue 1, 2011, Pages 125-128

  Ozgen, Metin ^a   Koca, Suleyman Serdar ^a   Dagli, Necati ^a   Balin, Mehmet ^b   Ustundag, Bilal ^a   Isik, Ahmet ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b Elazig Education and Research Hospital   (Turkey)

Author keywords

Atherosclerosis; Behcet's disease; Rheumatoid arthritis; Salusin

Indexed keywords

INTERLEUKIN 6; REGULATOR PROTEIN; SALUSIN ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BEHCET DISEASE; CAROTID ATHEROSCLEROSIS; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SEX DIFFERENCE;

ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BEHCET SYNDROME; BODY WEIGHTS AND MEASURES; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; MALE; MIDDLE AGED; SERUM; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

EID: 79951672212     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.12.003     Document Type: Article

References (24)

1. Cobb S., Anderson F., Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953, 249:553-556.
2. Ku I.A., Imboden J.B., Hsue P.Y., Ganz P. Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis. Circ J 2009, 73:977-985.
3. Aviña-Zubieta J.A., Choi H.K., Sadatsafavi M., Etminan M., Esdaile J.M., Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-1697.
4. Koca S.S., Karaca I., Yavuzkir M.F., Dagli N., Ozgen M., Ustündag B., Isik A. Insulin resistance is related with oxidative stress in systemic lupus erythematosus. Anadolu Kardiyol Derg 2009, 9:23-28.
5. Shichiri M., Ishimaru S., Ota T., Nishikawa T., Isogai T., Hirata Y. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 2003, 9:1166-1172.
6. Sato K., Fujimoto K., Koyama T., Shichiri M. Release of salusin-beta from human monocytes/macrophages. Regul Pept 2010, 162:68-72.
7. Sato K., Koyama T., Tateno T., Hirata Y., Shichiri M. Presence of immunoreactive salusin-alpha in human serum and urine. Peptides 2006, 27:2561-2566.
8. Sato K., Sato T., Susumu T., Koyama T., Shichiri M. Presence of immunoreactive salusin-beta in human plasma and urine. Regul Pept 2009, 158:63-67.
9. Izumiyama H., Tanaka H., Egi K., Sunamori M., Hirata Y., Shichiri M. Synthetic salusins as cardiac depressors in rat. Hypertension 2005, 45:419-425.
10. Yu F., Zhao J., Yang J., Gen B., Wang S., Feng X., et al. Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul Pept 2004, 122:191-197.
11. Watanabe T., Nishio K., Kanome T., Matsuyama T.A., Koba S., Sakai T., Sato K., Hongo S., Nose K., Ota H., Kobayashi Y., Katagiri T., Shichiri M., Miyazaki A. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008, 117:638-648.
12. Watanabe T., Suguro T., Sato K., Koyama T., Nagashima M., Kodate S., Hirano T., Adachi M., Shichiri M., Miyazaki A. Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens Res 2008, 31:463-468.
13. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
14. Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080. International Study Group for Behçet's Disease.
15. Leeb B.F., Andel I., Sautner J., Bogdan M., Maktari A., Nothnagl T., Rintelen B. Disease activity measurement of rheumatoid arthritis: comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine. Arthritis Rheum 2005, 53:56-60.
16. Koca S.S., Ozgen M., Aydin S., Dag S., Evren B., Isik A. Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation 2008, 31:329-335.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
18. Seyahi E., Yazici H. Atherosclerosis in Behçet's syndrome. Clin Exp Rheumatol 2007, 25:S1-S5.
19. Keser G., Aksu K., Tamsel S., Ozmen M., Kitapcioglu G., Kabaroglu C., et al. Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behçet's disease. Clin Exp Rheumatol 2005, 23:S71-S76.
20. Oztürk M.A., Oktar S.O., Unverdi S., Ureten K., Göker B., Haznedaroglu S., Sungur G., Reis K.A., Onat A.M. Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet's disease. Rheumatol Int 2006, 26:867-872.
21. Kimoto S., Sato K., Watanabe T., Suguro T., Koyama T., Shichiri M. Serum levels and urinary excretion of salusin-alpha in renal insufficiency. Regul Pept 2010, 162:129-132.
22. Sato K., Koyama T., Shichiri M. Biosynthesis and secretion of salusin-alpha from human cells. Peptides 2008, 29:2203-2207.
23. Ozgen M., Koca S.S., Isik B., Dagli N., Ustundag B., Isik A. Serum salusin-α level in systemic sclerosis. [abstract] 1st Systemic Sclerosis World Congress. Clin Exp Rheumatol 2010, 103.
24. Xiao-Hong Y., Li L., Yan-Xia P., Hong L., Wei-Fang R., Yan L., An-Jing R., Chao-Shu T., Wen-Jun Y. Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78. J Cardiovasc Pharmacol 2006, 48:41-46.